Health ❯Pharmaceuticals

Drug Candidates

Obesity Treatments Clinical Trials

Monte Rosa Therapeutics' Stock Soars After $2.1 Billion Deal with Novartis

Roche Accelerates Obesity Drug Development, Projects $3.6 Billion in Annual Sales